TWO · 6917.TWO
Andros Pharmaceuticals Co.,Ltd
NT$32.25-NT$0.90 (-2.71%)
Andros Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.82% below the high.
Loading market information…
TWO · 4188.TWO · TWD
Stock price, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
AmCad BioMed Corporation’s quoted price sits in the upper half of its reported 52-week range, 18.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow AmCad BioMed Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$32.25-NT$0.90 (-2.71%)
Andros Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.82% below the high.
NT$71.70+NT$0.20 (+0.28%)
Puriblood Medical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.48% below the high.
NT$13.95-NT$0.05 (-0.36%)
LAUNXP Biomedical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 45.19% below the high.
NT$15.85-NT$0.20 (-1.25%)
Radiant Innovation Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.7% below the high.
NT$15.50NT$0.00 (0.0%)
NatureWise Biotech & Medicals Corporation’s quoted price sits in the lower half of its reported 52-week range, 36.99% below the high.
NT$18.65NT$0.00 (0.0%)
TFBS Bioscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.03% below the high.
NT$6.35-NT$0.34 (-5.08%)
PlexBio Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.81% below the high.
NT$16.90+NT$0.40 (+2.42%)
SynCore Biotechnology Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.32% below the high.
